methylprednisolone has been researched along with memantine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Li-Li, M; Seiger, A; Sundström, E; von Euler, M; Whittemore, S | 1 |
| Ikeda, K; Iwamoto, K; Iwasaki, Y; Mizumura, S; Tachiki, K; Yanagihashi, M | 1 |
1 review(s) available for methylprednisolone and memantine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for methylprednisolone and memantine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
No protective effect of the NMDA antagonist memantine in experimental spinal cord injuries.
Topics: Adult; Animals; Anti-Inflammatory Agents; Behavior, Animal; Binding, Competitive; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Humans; In Vitro Techniques; Kinetics; Memantine; Membranes; Methylprednisolone; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Spinal Cord Compression; Spinal Cord Injuries | 1997 |
Combined treatment of methylprednisolone pulse and memantine hydrochloride prompts recovery from neurological dysfunction and cerebral hypoperfusion in carbon monoxide poisoning: a case report.
Topics: Antiparkinson Agents; Carbon Monoxide Poisoning; Cerebrovascular Circulation; Cerebrovascular Disorders; Drug Therapy, Combination; Glucocorticoids; Humans; Hyperbaric Oxygenation; Male; Memantine; Methylprednisolone; Middle Aged; Neurotoxicity Syndromes; Parkinson Disease, Secondary; Perfusion Imaging; Pulse Therapy, Drug; Recovery of Function; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2014 |